219
Views
12
CrossRef citations to date
0
Altmetric
Review

Measuring Anterior Chamber Inflammation After Cataract Surgery: A Review of the Literature Focusing on the Correlation with Cystoid Macular Edema

ORCID Icon, , , & ORCID Icon
Pages 41-52 | Published online: 09 Jan 2020

References

  • Wang W, Yan W, Fotis K, et al. Cataract surgical rate and socioeconomics: a global study. Invest Ophthalmol Vis Sci. 2016. doi:10.1167/iovs.16-19894
  • Davis G. The evolution of cataract surgery. Mo Med. 2016.
  • Kim SJ, Schoenberger SD, Thorne JE, et al. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122:2159–2168. doi:10.1016/j.ophtha.2015.05.014
  • McCafferty S, Harris A, Kew C, et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017;17. doi:10.1186/s12886-017-0405-7
  • Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76:221–224. doi:10.1136/bjo.76.4.221
  • Schmier JK, Halpern MT, Covert DW, Matthews GP. Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina. 2007;27:621–628. doi:10.1097/01.iae.0000249577.92800.c0
  • Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery a database study of 81984 eyes. Ophthalmology. 2016;123:316–323. doi:10.1016/j.ophtha.2015.10.001
  • Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998. doi:10.1136/bjo.2004.047662
  • Gulkilik G, Kocabora S, Taskapili M, Engin G. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol. 2007. doi:10.1139/i06-062
  • Bélair M-L, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol. 2009;148(1):128–35.e2. doi:10.1016/j.ajo.2009.02.029
  • Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33:1550–1558. doi:10.1016/j.jcrs.2007.05.013
  • Coassin M, Iovieno A, Soldani A, et al. Bromfenac ophthalmic solution 0. 09 % as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome. J Cataract Refract Surg. 2018:1119–1125. doi:10.1016/j.jcrs.2016.04.031
  • Perente I, Utine CA, Ozturker C, et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res. 2007;32:241–247. doi:10.1080/02713680601160610
  • Vukicevic M, Gin T, Al-Qureshi S. Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco-emulsification cataract surgery. Clin Exp Ophthalmol. 2012;40:282–287. doi:10.1111/j.1442-9071.2011.02638.x
  • Rossetti L, Autelitano A. Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol. 2000;11:65–72. doi:10.1097/00055735-200002000-00010
  • Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47:S203–S218. doi:10.1016/S0039-6257(02)00294-1
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005. doi:10.1016/j.ajo.2005.03.057
  • Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol. 1988;32(2):132–142.
  • Jones VS, Wu J, Zhu SW, Huang RP. Application of multiplex immunoassay technology to investigations of ocular disease. Expert Rev Mol Med. 2016;18. doi:10.1017/erm.2016.15
  • Rossetti L, Bujtar E, Castoldi D, Torrazza C, Orzalesi N. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. J Cataract Refract Surg. 1996;22:794–799. doi:10.1016/S0886-3350(96)80164-7
  • Gallenga PE, Mastropasqua L, Lobefalo L, et al. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg. 1997;23:1183–1189. doi:10.1016/S0886-3350(97)80313-6
  • Conrad-Hengerer I, Hengerer FH, Al Juburi M, Schultz T, Dick HB. Femtosecond laser-induced macular changes and anterior segment inflammation in cataract surgery. J Refract Surg. 2014;30:222–226. doi:10.3928/1081597x-20140321-01
  • Zaczek A, Artzen D, Laurell CG, Stenevi U, Montan P. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery. J Cataract Refract Surg. 2014;40:1498–1505. doi:10.1016/j.jcrs.2013.12.023
  • Giannaccare G, Finzi A, Sebastiani S, Greco F, Versura P, Campos EC. The comparative efficacy and tolerability of diclofenac 0.1% and Bromfenac 0.09% ophthalmic solutions after cataract surgery. Curr Eye Res. 2018;43:1445–1453. doi:10.1080/02713683.2018.1501489
  • Wielders LHP, Schouten JSAG, Winkens B, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429–439. doi:10.1016/j.jcrs.2018.01.029
  • Coassin M, De Maria M, Mastrofilippo V, et al. Anterior chamber inflammation after cataract surgery: a randomized clinical trial comparing Bromfenac 0.09% to Dexamethasone 0.1%. Adv Ther. 2019;36:2712–2722. doi:10.1007/s12325-019-01076-4
  • Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood- aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25:1492–1497. doi:10.1016/S0886-3350(99)00196-0
  • Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32:1474–1482. doi:10.1016/j.jcrs.2006.04.009
  • Miyanaga M, Miyai T, Nejima R, Maruyama Y, Miyata K, Kato S. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmol. 2009;87:300–305. doi:10.1111/j.1755-3768.2008.01433.x
  • Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Am J Ophthalmol. 2010;149:777–784. doi:10.1016/j.ajo.2009.12.010
  • Dieleman M, Wubbels RJ, Van Kooten-noordzij M, De Waard PWT. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37:1589–1597. doi:10.1016/j.jcrs.2011.03.049
  • Chu L, Wang B, Xu B, Dong N. Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Mol Vis. 2013;19:2418–2425.
  • Wang QW, Yao K, Xu W, et al. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica. 2013;229:187–194. doi:10.1159/000346847
  • Ersoy L, Caramoy A, Ristau T, Kirchhof B, Fauser S. Aqueous flare is increased in patients with clinically significant cystoid macular oedema after cataract surgery. Br J Ophthalmol. 2013;97:862–865. doi:10.1136/bjophthalmol-2012-302995
  • Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with Uveitis. Am J Ophthalmol. 2008;146:813–818.e1. doi:10.1016/j.ajo.2008.06.004
  • Wong IG, Nugent AK, Vargas-Martín F. The effect of biomicroscope illumination system on grading anterior chamber inflammation. Am J Ophthalmol. 2009;148:516–520.e2. doi:10.1016/j.ajo.2009.04.027
  • Sen HN, Read RW. In: Sen HN, Read RW, editors. Multimodal Imaging in Uveitis. Cham: Springer International Publishing; 2018. doi:10.1007/978-3-319-23690-2
  • Sharma S, Lowder CY, Vasanji A, Baynes K, Kaiser PK, Srivastava SK. Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography. Ophthalmology. 2015;122:1464–1470. doi:10.1016/j.ophtha.2015.02.032
  • Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30:453–464. doi:10.1007/s10792-009-9310-2
  • Shah SM, Spalton DJ, Smith SE. Measurement of aqueous cells and flare in normal Eyes. Br J Ophthalmol. 1991. doi:10.1136/bjo.75.6.348
  • Onodera T, Gimbel HV, DeBroff BM. Aqueous flare and cell number in healthy eyes of Caucasians. Jpn J Ophthalmol. 1993;37(4):445–451.
  • Guillén-Monterrubio OM, Hartikainen J, Taskinen K, Saari KM. Quantitative determination of aqueous flare and cells in healthy eyes. Acta Ophthalmol Scand. 2009;75(1):58–62. doi:10.1111/j.1600-0420.1997.tb00251.x
  • Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN. Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol. 2005;50(1):27–47. doi:10.1016/j.survophthal.2004.10.004
  • Rodinger ML, Hessemer V, Schmitt K, Schickel B [Reproducibility of in vivo determination of protein and particle concentration with the laser flare cell photometer]. Reproduzierbarkeit der in-vivo-Bestimmung von Eiweiss- und Partikelkonzentration mit dem Laser-flare-cell-Photometer. 1993.
  • Saari KM, Guillen-Monterrubio OM, Hartikainen J, Hamalainen MM, Taskinen K. Measurement of protein concentration of aqueous humour in vivo: correlation between laser flare measurements and chemical protein determination. Acta Ophthalmol Scand. 1997.
  • Guillén-Monterrubío OM, Hartikainen J, Taskinen K, Saari KM. Quantitative determination of aqueous flare and cells in healthy eyes. Acta Ophthalmol Scand. 1997;75(1):58–62. doi:10.1111/j.1600-0420.1997.tb00251.x
  • El-Harazi SM, Ruiz RS, Feldman RM, Chuang AZ, Villanueva G. Quantitative assessment of aqueous flare: the effect of age and pupillary dilation. Ophthalmic Surg Lasers. 2002. 33(5):379–82.
  • Laurell CG, Zetterström C, Philipson B, Syrén-Nordqvist S. Randomized study of the blood-aqueous barrier reaction after phacoemulsification and extracapsular cataract extraction. Acta Ophthalmol Scand. 1998;76:573–578. doi:10.1034/j.1600-0420.1998.760512.x
  • Dick HB, Schwenn O, Krummenauer F, Krist R, Pfeiffer N. Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification. Ophthalmology. 2000;107:241–247. doi:10.1016/S0161-6420(99)00082-2
  • Schwenn O, Dick HB, Krummenauer F, Christmann S, Vogel A, Pfeiffer N. Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes. Graefe’s Arch Clin Exp Ophthalmol. 2000;238:861–867. doi:10.1007/s004170000192
  • Herbort CP, Jauch A, Othenin-Girard P, Tritten JJ, Fsadni M. Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand. 2000;78:421–424. doi:10.1034/j.1600-0420.2000.078004421.x
  • Laurell CG, Zetterström C. Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Br J Ophthalmol. 2002;86:1380–1384. doi:10.1136/bjo.86.12.1380
  • De Maria M, Coassin M, Mastrofilippo V, Fontana L. Quantitative evaluation of anterior chamber inflammation after phacoemulsification in clinical trials. J Cataract Refract Surg. 2018;44:9. doi:10.1016/j.jcrs.2018.06.043
  • Saito M, Barbazetto IA, Spaide RF. Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease. Retina. 2013;33:559–565. doi:10.1097/IAE.0b013e31826710ea
  • Keane PA, Karampelas M, Sim DA, et al. Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology. 2014;121:1706–1714. doi:10.1016/j.ophtha.2014.03.006
  • Agarwal A, Ashokkumar D, Jacob S, Agarwal A, Saravanan Y. High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading. Am J Ophthalmol. 2009;147:413–416.e3. doi:10.1016/j.ajo.2008.09.024
  • Li Y, Lowder C, Zhang X, Huang D. Anterior chamber cell grading by optical coherence tomography. Invest Opthalmol Vis Sci. 2013;54(1):258. doi:10.1167/iovs.12-10477
  • Igbre AO, Rico MC, Garg SJ. High-speed optical coherence tomography as a reliable adjuvant tool to grade ocular anterior chamber inflammation. Retina. 2014;34:504–508. doi:10.1097/IAE.0b013e31829f73bd
  • Invernizzi A, Marchi S, Aldigeri R, et al. Objective quantification of anterior chamber inflammation: measuring cells and flare by anterior segment optical coherence tomography. Ophthalmology. 2017;124:1670–1677. doi:10.1016/j.ophtha.2017.05.013
  • Reichel E. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography: comment. Evidence-Based Ophthalmol. 2010. doi:10.1097/IEB.0b013e3181c70df4
  • Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131–147. doi:10.1023/A:1007074420772
  • Pietrowska K, Dmuchowska DA, Krasnicki P, Mariak Z, Kretowski A, Ciborowski M. Analysis of pharmaceuticals and small molecules in aqueous humor. J Pharm Biomed Anal. 2018;159:23–36. doi:10.1016/j.jpba.2018.06.049
  • Chowdhury UR, Madden BJ, Charlesworth MC, Fautsch MP. Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci. 2010;51:4921. doi:10.1167/iovs.10-5531
  • Du S, Huang W, Zhang X, Wang J, Wang W, Lam DSC. Multiplex cytokine levels of aqueous humor in acute primary angle-closure patients: fellow eye comparison Glaucoma. BMC Ophthalmol. 2016;16. doi:10.1186/s12886-016-0182-8.
  • Vignali DAA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243–255. doi:10.1016/S0022-1759(00)00238-6
  • Liu YC, Setiawan M, Ang M, Yam GHF, Mehta JS. Changes in aqueous oxidative stress, prostaglandins, and cytokines: comparisons of low-energy femtosecond laser–assisted cataract surgery versus conventional phacoemulsification. J Cataract Refract Surg. 2019;45:196–203. doi:10.1016/j.jcrs.2018.09.022